Latest News
Treace Medical (TMCI) Q3 2026 Earnings Call Transcriptfool.com
Product mix shifted lower as adjusted EBITDA turned positive this quarter.
Via The Motley Fool · November 6, 2026
Telephone Data (TDS) Q3 2026 Earnings Call Transcriptfool.com
Fiber gains accelerate while legacy declines weigh on updated guidance.
Via The Motley Fool · November 6, 2026
Brookfield Infra (BIP) Q3 2026 Earnings Call Transcriptfool.com
Data and transport drove 10% FFO growth before a planned restructuring.
Via The Motley Fool · November 6, 2026
Alpha Metallurgical (AMR) Q3 2026 Earnings Call Transcriptfool.com
Higher shipments and cost pressures shape the 2027 outlook.
Via The Motley Fool · November 6, 2026
Array Digital (AD) Q3 2026 Earnings Call Transcriptfool.com
Fiber gains surged while legacy declines forced a guidance cut.
Via The Motley Fool · November 6, 2026
Shopify Stock Falls Despite Strong AI-Powered Growth. Should Investors Buy the Dip?fool.com
Shopify stock fell after the company's revenue and GMV results fell short of analyst expectations.
Via The Motley Fool · November 6, 2026
Why Firefly Aerospace Stock Went to the Moon Todayfool.com
Firefly just agreed to sell AST SpaceMobile $1.3 billion worth of rocket engines.
Via The Motley Fool · November 6, 2026
Guardian Pharma (GRDN) Q3 2026 Earnings Call Transcriptfool.com
Debt-free balance sheet and rising occupancy shape its expansion plans.
Via The Motley Fool · November 6, 2026
Mettler-Toledo (MTD) Q3 2026 Earnings Call Transcriptfool.com
Asia strength and automation demand carried quarterly results, while Europe stays uncertain.
Via The Motley Fool · November 6, 2026
Farmer Mac (AGM) Q3 2026 Earnings Call Transcriptfool.com
Management sees its $40 billion volume goal arriving two years early
Via The Motley Fool · November 6, 2026
DraftKings (DKNG) Q3 2026 Earnings Call Transcriptfool.com
Predictions spending climbs as management maps a path back to profit.
Via The Motley Fool · November 6, 2026
RenovoRx (RNXT) Q3 2026 Earnings Call Transcriptfool.com
Zero-margin device conversions weighed on margins this quarter, management says.
Via The Motley Fool · November 6, 2026
Puma Biotechnology (PBYI) Q3 2026 Earnings Call Transcriptfool.com
International shipments kept third-quarter revenue steady despite softer domestic NERLYNX sales.
Via The Motley Fool · November 6, 2026
Fulgent Genetics (FLGT) Q3 2026 Earnings Call Transcriptfool.com
A tax refund and bad debt recovery shaped results and lifted the outlook.
Via The Motley Fool · November 6, 2026
Anika Therapeutics (ANIK) Q3 2026 Earnings Call Transcriptfool.com
Record commercial sales and a raised margin outlook drove the quarter.
Via The Motley Fool · November 6, 2026
Enbridge (ENB) Q3 2026 Earnings Call Transcriptfool.com
Enbridge posts higher adjusted earnings and reaffirms its full-year targets.
Via The Motley Fool · November 6, 2026
3 High-Yield Healthcare Stocks to Buy With $1,000 and Hold Through Any Marketfool.com
They are so much more than just dividend stocks.
Via The Motley Fool · November 6, 2026
AOS (AOSL) Q1 2027 Earnings Call Transcriptfool.com
AI server growth offset a steep PC slump, lifting margins for the quarter.
Via The Motley Fool · November 6, 2026
Blend Labs (BLND) Q3 2026 Earnings Call Transcriptfool.com
Autopilot growth and a record sales quarter sit alongside a weaker mortgage outlook.
Via The Motley Fool · November 6, 2026
BJ's Restaurants (BJRI) Q3 2026 Earnings Call Transcriptfool.com
Margins widened and debt nearly vanished as traffic kept climbing this quarter.
Via The Motley Fool · November 6, 2026
Accendra (ACH) Q3 2026 Earnings Call Transcriptfool.com
Management outlines a turnaround plan as profit improvement falls short of expectations.
Via The Motley Fool · November 6, 2026
ePlus inc. (PLUS) Q2 2027 Earnings Call Transcriptfool.com
Record billings and raised guidance point to strong AI-driven demand.
Via The Motley Fool · November 6, 2026
Mobia Medical (MOBI) Q3 2026 Earnings Call Transcriptfool.com
New guideline recognition is fueling this stroke device maker's commercial expansion.
Via The Motley Fool · November 6, 2026
INmune Bio (INMB) Q3 2026 Earnings Call Transcriptfool.com
Management outlined a revised UK submission strategy and early named patient access plans for Ebstracel.
Via The Motley Fool · November 6, 2026
Westrock Coffee (WEST) Q3 2026 Earnings Call Transcriptfool.com
Conway runs at 40% capacity, with a path toward far higher utilization ahead.
Via The Motley Fool · November 6, 2026
